tradingkey.logo
๎™

WW International Inc

WW
27.720USD
-2.400-7.97%
์ข…๊ฐ€ย 12/26, 16:00๏ผˆET๏ผ‰์‹œ์„ธ๋Š” 15๋ถ„ ์ง€์—ฐ๋ฉ๋‹ˆ๋‹ค
276.84M์‹œ๊ฐ€์ด์•ก
0.26P/E TTM
๎™

์ž์„ธํ•œ ๋‚ด์šฉ์€ WW International Inc ํšŒ์‚ฌ

WW International, Inc. provides science-backed weight loss and weight management programs. The Company provides an accessible, holistic model of care through its doctor-recommended Points Program, clinical interventions including weight-loss medications, and community support. Its weight-loss and weight management programs are focused on nutritional and behavior change science. They are comprised of a range of science-based nutritional, activity, behavioral and lifestyle tools and approaches that can be tailored for individual weight goals and, if needed, support the various needs of people taking GLP-1 medications. Its offerings include Behavior Change Programs, WeightWatchers Clinic, Licensing and Consumer Product Sales. Its subscription businesses include digital business, workshops + digital business, clinical business and WeightWatchers for business offering nutritional and behavior change science. Its WW-branded products include bars, snacks, cookbooks and kitchen tools.

WW International Inc ์ •๋ณด

๎™Œ
์ข…๋ชฉ ์ฝ”๋“œ WW
ํšŒ์‚ฌ ์ด๋ฆ„WW International Inc
์ƒ์žฅ์ผNov 15, 2001
CEOComonte (Tara)
์ง์› ์ˆ˜3700
์œ ํ˜•Ordinary Share
ํšŒ๊ณ„ ์—ฐ๋„ ์ข…๋ฃŒNov 15
์ฃผ์†Œ18 West 18Th Street
๋„์‹œNEW YORK
์ฆ๊ถŒ ๊ฑฐ๋ž˜์†ŒNASDAQ OMX - NASDAQ BASIC
๊ตญ๊ฐ€United States of America
์šฐํŽธ ๋ฒˆํ˜ธ10011
์ „ํ™”12125892700
์›น์‚ฌ์ดํŠธhttps://www.weightwatchers.com/us/
์ข…๋ชฉ ์ฝ”๋“œ WW
์ƒ์žฅ์ผNov 15, 2001
CEOComonte (Tara)

WW International Inc์˜ ํšŒ์‚ฌ ์ž„์›์ง„

๎™Œ
์ด๋ฆ„
์ด๋ฆ„/์ง์œ„
์ง์œ„
์ฃผ์‹ ๋ณด์œ 
๋ณ€๋™
Mr. Michael Amsel
Mr. Michael Amsel
Chief Marketing Officer
Chief Marketing Officer
3.43K
--
Ms. Uta Knablein
Ms. Uta Knablein
Chief Product Officer
Chief Product Officer
--
--
Ms. Jacquie Cooke
Ms. Jacquie Cooke
Chief Legal and Administrative Officer and Secretary
Chief Legal and Administrative Officer and Secretary
--
--
Ms. Felicia Dellafortuna
Ms. Felicia Dellafortuna
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Julie Bornstein
Ms. Julie Bornstein
Independent Director
Independent Director
--
--
Dr. Fallon O'Connor-Brooks
Dr. Fallon O'Connor-Brooks
Independent Director
Independent Director
--
--
Mr. John Mills
Mr. John Mills
IR Contact Officer
IR Contact Officer
--
--
Ms. Tara Comonte
Ms. Tara Comonte
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Nikolaj H. Sjoqvist
Mr. Nikolaj H. Sjoqvist
Independent Director
Independent Director
--
--
Mr. Eugene Irwin (Gene) Davis, J.D.
Mr. Eugene Irwin (Gene) Davis, J.D.
Independent Director
Independent Director
--
--
๋” ๋ณด๊ธฐ
์ด๋ฆ„
์ด๋ฆ„/์ง์œ„
์ง์œ„
์ฃผ์‹ ๋ณด์œ 
๋ณ€๋™
Mr. Michael Amsel
Mr. Michael Amsel
Chief Marketing Officer
Chief Marketing Officer
3.43K
--
Ms. Uta Knablein
Ms. Uta Knablein
Chief Product Officer
Chief Product Officer
--
--
Ms. Jacquie Cooke
Ms. Jacquie Cooke
Chief Legal and Administrative Officer and Secretary
Chief Legal and Administrative Officer and Secretary
--
--
Ms. Felicia Dellafortuna
Ms. Felicia Dellafortuna
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Julie Bornstein
Ms. Julie Bornstein
Independent Director
Independent Director
--
--
Dr. Fallon O'Connor-Brooks
Dr. Fallon O'Connor-Brooks
Independent Director
Independent Director
--
--

์ˆ˜์ต ๋ถ„์„

ํ†ตํ™”: USD๋งˆ์ง€๋ง‰ ์—…๋ฐ์ดํŠธ: Mon, Oct 6
ํ†ตํ™”: USD๋งˆ์ง€๋ง‰ ์—…๋ฐ์ดํŠธ: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
์‚ฌ์—…๋ณ„USD
์ด๋ฆ„
์ˆ˜์ต
๋น„์œจ
Behavioral Subscription Revenues
157.26M
83.13%
Clinical Subscription Revenues
30.59M
16.17%
Product Sales And Other
1.31M
0.69%
๊ธฐ์—…์ด ์•„์ง ๊ด€๋ จ ๋ฐ์ดํ„ฐ๋ฅผ ๊ณต๊ฐœํ•˜์ง€ ์•Š์•˜์Šต๋‹ˆ๋‹ค.
์‚ฌ์—…๋ณ„
์ง€์—ญ๋ณ„
์‚ฌ์—…๋ณ„USD
์ด๋ฆ„
์ˆ˜์ต
๋น„์œจ
Behavioral Subscription Revenues
157.26M
83.13%
Clinical Subscription Revenues
30.59M
16.17%
Product Sales And Other
1.31M
0.69%

์ฃผ์‹ ๋ณด์œ  ํ†ต๊ณ„

๋งˆ์ง€๋ง‰ ์—…๋ฐ์ดํŠธ: Sat, Nov 22
๋งˆ์ง€๋ง‰ ์—…๋ฐ์ดํŠธ: Sat, Nov 22
์ฃผ์ฃผ
์ฃผ์ฃผ ์œ ํ˜•
์ฃผ์ฃผ
์ฃผ์ฃผ
๋น„์œจ
Aristeia Capital, L.L.C.
9.01%
Carronade Capital Management LP
4.47%
JPMorgan Private Bank (United States)
3.82%
Contrarius Investment Management Ltd.
3.77%
Balyasny Asset Management LP
2.98%
๊ธฐํƒ€
75.95%
์ฃผ์ฃผ
์ฃผ์ฃผ
๋น„์œจ
Aristeia Capital, L.L.C.
9.01%
Carronade Capital Management LP
4.47%
JPMorgan Private Bank (United States)
3.82%
Contrarius Investment Management Ltd.
3.77%
Balyasny Asset Management LP
2.98%
๊ธฐํƒ€
75.95%
์ฃผ์ฃผ ์œ ํ˜•
์ฃผ์ฃผ
๋น„์œจ
Hedge Fund
24.44%
Investment Advisor
17.21%
Investment Advisor/Hedge Fund
11.88%
Bank and Trust
3.91%
Research Firm
2.51%
Pension Fund
0.55%
Individual Investor
0.33%
Family Office
0.20%
Holding Company
0.09%
๊ธฐํƒ€
38.87%

๊ธฐ๊ด€ ์ฃผ์‹ ๋ณด์œ 

๎™Œ
๋งˆ์ง€๋ง‰ ์—…๋ฐ์ดํŠธ: Wed, Oct 1
๋งˆ์ง€๋ง‰ ์—…๋ฐ์ดํŠธ: Wed, Oct 1
๋ณด๊ณ  ๊ธฐ๊ฐ„
๊ธฐ๊ด€ ์ˆ˜
๋ณด์œ  ์ฃผ์‹
๋น„์œจ
๋ณ€๋™
2025Q3
41
3.62M
36.25%
+974.95K
2025Q2
438
20.10M
24.64%
-32.99M
2025Q1
458
16.66M
20.68%
-36.51M
2024Q4
499
19.89M
24.83%
-54.79M
2024Q3
507
25.03M
31.39%
-59.37M
2024Q2
538
34.23M
43.18%
-58.37M
2024Q1
551
46.66M
58.89%
-51.69M
2023Q4
557
67.86M
85.74%
-30.15M
2023Q3
550
65.35M
82.74%
-28.31M
2023Q2
560
59.72M
75.99%
-24.95M
๋” ๋ณด๊ธฐ

์ฃผ์ฃผ ํ™œ๋™

๎™Œ
์ด๋ฆ„
๋ณด์œ  ์ฃผ์‹
๋น„์œจ
๋ณ€๋™
Chg %
๋‚ ์งœ
Aristeia Capital, L.L.C.
1.40M
13.97%
--
--
Jul 07, 2025
Aegon Asset Management US
110.15K
1.1%
--
--
Aug 31, 2025
Millennium Management LLC
437.59K
4.38%
+437.59K
--
Aug 04, 2025
Arini Capital Management Limited
278.89K
2.79%
-360.61K
-56.39%
Jul 07, 2025
Invesco Advisers, Inc.
69.68K
0.7%
-13.88K
-16.61%
Aug 31, 2025
๋” ๋ณด๊ธฐ

๊ด€๋ จ ETF

๎™Œ
๋งˆ์ง€๋ง‰ ์—…๋ฐ์ดํŠธ: Sat, Dec 6
๋งˆ์ง€๋ง‰ ์—…๋ฐ์ดํŠธ: Sat, Dec 6
์ด๋ฆ„
๋น„์œจ
Acquirers Small and Micro Deep Value ETF
1.11%
Acquirers Small and Micro Deep Value ETF
๋น„์œจ1.11%

์ฃผ์‹ ๋ฐฐ๋‹น๊ธˆ

๎™Œ
์ง€๋‚œ 5๋…„ ๋™์•ˆ ์ด 0.00 USD์˜ ๋ฐฐ๋‹น๊ธˆ์ด ๋ถ„๋ฐฐ๋˜์—ˆ์Šต๋‹ˆ๋‹ค.
๋‚ ์งœ
๋ฐฐ๋‹น๊ธˆ
๊ธฐ์ค€์ผ
์ง€๊ธ‰์ผ
๋ฐฐ๋‹น๋ฝ์ผ
๋ฐ์ดํ„ฐ ์—†์Œ

์ฃผ์‹ ๋ถ„ํ• 

๎™Œ
๋‚ ์งœ
์œ ํ˜•
๋น„์œจ
๋ฐ์ดํ„ฐ ์—†์Œ
๋‚ ์งœ
์œ ํ˜•
๋น„์œจ
๋ฐ์ดํ„ฐ ์—†์Œ

์ž์ฃผ ๋ฌป๋Š” ์งˆ๋ฌธ

WW International Inc์˜ ์ƒ์œ„ 5๋Œ€ ์ฃผ์ฃผ๋Š” ๋ˆ„๊ตฌ์ธ๊ฐ€์š”?

๎™Œ
WW International Inc์˜ ์ƒ์œ„ 5๋Œ€ ์ฃผ์ฃผ๋Š” ๋‹ค์Œ๊ณผ ๊ฐ™์Šต๋‹ˆ๋‹ค:
Aristeia Capital, L.L.C.๋Š” 1.40M์ฃผ์˜ ์ฃผ์‹์„ ๋ณด์œ ํ•˜๊ณ  ์žˆ์œผ๋ฉฐ, ์ „์ฒด ์ฃผ์‹์˜ 13.97%๋ฅผ ์ฐจ์ง€ํ•ฉ๋‹ˆ๋‹ค.
Aegon Asset Management US๋Š” 110.15K์ฃผ์˜ ์ฃผ์‹์„ ๋ณด์œ ํ•˜๊ณ  ์žˆ์œผ๋ฉฐ, ์ „์ฒด ์ฃผ์‹์˜ 1.10%๋ฅผ ์ฐจ์ง€ํ•ฉ๋‹ˆ๋‹ค.
Millennium Management LLC๋Š” 437.59K์ฃผ์˜ ์ฃผ์‹์„ ๋ณด์œ ํ•˜๊ณ  ์žˆ์œผ๋ฉฐ, ์ „์ฒด ์ฃผ์‹์˜ 4.38%๋ฅผ ์ฐจ์ง€ํ•ฉ๋‹ˆ๋‹ค.
Arini Capital Management Limited๋Š” 278.89K์ฃผ์˜ ์ฃผ์‹์„ ๋ณด์œ ํ•˜๊ณ  ์žˆ์œผ๋ฉฐ, ์ „์ฒด ์ฃผ์‹์˜ 2.79%๋ฅผ ์ฐจ์ง€ํ•ฉ๋‹ˆ๋‹ค.
Invesco Advisers, Inc.๋Š” 69.68K์ฃผ์˜ ์ฃผ์‹์„ ๋ณด์œ ํ•˜๊ณ  ์žˆ์œผ๋ฉฐ, ์ „์ฒด ์ฃผ์‹์˜ 0.70%๋ฅผ ์ฐจ์ง€ํ•ฉ๋‹ˆ๋‹ค.

WW International Inc์˜ ์ƒ์œ„ 3๋Œ€ ์ฃผ์ฃผ ์œ ํ˜•์€ ๋ฌด์—‡์ธ๊ฐ€์š”?

๎™Œ
WW International Inc์˜ ์ฃผ์š” ์ฃผ์ฃผ ์œ ํ˜• ์ƒ์œ„ 3๊ฐ€์ง€๋Š”
Aristeia Capital, L.L.C.
Carronade Capital Management LP
JPMorgan Private Bank (United States)์ž…๋‹ˆ๋‹ค.

WW International Inc(WW)์˜ ์ฃผ์‹์„ ๋ณด์œ ํ•œ ๊ธฐ๊ด€์€ ๋ช‡ ๊ฐœ์ž…๋‹ˆ๊นŒ?

๎™Œ
2025Q3 ๊ธฐ์ค€์œผ๋กœ, WW International Inc์˜ ์ฃผ์‹์„ ๋ณด์œ ํ•œ ๊ธฐ๊ด€์€ ์ด 41๊ณณ์ด๋ฉฐ, ์ด๋“ค์ด ๋ณด์œ ํ•œ ์ฃผ์‹์˜ ์ด ๊ฐ€์น˜๋Š” ์•ฝ 3.62M๋กœ ์ „์ฒด ๋ฐœํ–‰ ์ฃผ์‹์˜ 36.25%๋ฅผ ์ฐจ์ง€ํ•ฉ๋‹ˆ๋‹ค. ์ด๋Š” 2025Q2 ๋Œ€๋น„ 11.61% ์ฆ๊ฐ€ํ•œ ์ˆ˜์น˜์ž…๋‹ˆ๋‹ค.

WW International Inc์˜ ์ตœ๋Œ€ ์ˆ˜์ต์›์€ ๋ฌด์—‡์ธ๊ฐ€์š”?

๎™Œ
FY2025Q2 ๊ธฐ์ค€, WW International Inc์˜ Behavioral Subscription Revenues ๋ถ€๋ฌธ์ด ๊ฐ€์žฅ ๋†’์€ ๋งค์ถœ์„ ๊ธฐ๋กํ–ˆ์œผ๋ฉฐ, ๊ธˆ์•ก์€ 157.26M๋กœ ์ „์ฒด ๋งค์ถœ์˜ 83.13%๋ฅผ ์ฐจ์ง€ํ–ˆ์Šต๋‹ˆ๋‹ค.
KeyAI
๎™